Diabetes Care 43:18361842 Buitinga M, Callebaut A, Marques Cmara Sodr F, Crvecoeur I, Blahnik-Fagan G, Yang ML, Bugliani M, Arribas-Layton D, Marr M, Cook DP, Waelkens E, Mallone R, Piganelli JD, Marchetti P, Mamula MJ, Derua R, James EA, Mathieu C, Overbergh L (2018) Inflammation-induced citrullinated glucose-regulated protein 78 elicits immune responses in human type 1 diabetes
The five-plus-year safety profile for semaglutide is reassuring
Semaglutide# Semaglutide is a 31-amino acid GLP-1 receptor agonist with a C18 fatty diacid enabling albumin binding and a 7-day half-life
6-Gingerol alleviates ferroptosis and inflammation of diabetic cardiomyopathy via the Nrf2/HO-1 pathway
These gastrointestinal side effects occur because your stomach lining becomes hypersensitive to rapid increases in GLP-1 signaling